Article
Developing an Innovative Web-Based Machine Learning Tool for Predicting Delayed Methotrexate Elimination in Pediatric Patients with Osteosarcoma
2025-03-26
Abstract excerpt
not-yet-known not-yet-known not-yet-known unknown Background: Pediatric osteosarcoma treatment with high-dose methotrexate (HD-MTX) risks delayed clearance due to immature organ function. Interpretable machine learning enables proactive prediction, improving monitoring and reducing toxicity risks effectively. <h4>Methods:</h4> This retrospective study (2020–2024) on pediatric patients with osteosarcoma treated...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c001934d-db17-5484-8ed2-f688fcc7648a
- DOI
- 10.22541/au.174298884.47399956/v1
